KrowkaMJ. Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis. 2006;26(3):265–272.
2.
AbbasAEFortuinFDSchillerNBAppletonCPMorenoCALesterSJ. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol. 2003;41(6):1021–1027.
3.
GinesPSchrierRW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279–1290.
4.
NavasaMFolloAFilellaX. Tumor necrosis facto rand interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology. 1998;27(5):1227–1232.
5.
BudhirajaRHassounPM. Portopulmonary hypertension. A tale of two circulations. Chest. 2003;123(2):562–576.
6.
PellicelliAMBarbaroGPuotiC. Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation. Angiology. 2010;61(8):802–806.
WongFMooreKDingemanseJJalanR. Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome. Hepatology. 2008;47(1):160–168.
9.
BenjaminovFSPrenticeMSnidermanKWSiuSWongF. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut. 2003;52(9):1355–1362.
10.
Farzaneh-FarRMcKeownBHDangDRobertsJSchillerNBFosterE. Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. Am J Cardiol. 2008;101(2):259–262.
11.
ScapellatoFTemporelliPLEleuteriECorraUImparatoAGiannuzziP. Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic heart failure. J Am Coll Cardiol. 2001;37(7):1813–1819.
12.
ShermanDSFishDNTeitelbaumI. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003;41(2):269–278.
